Cubist Systematic Strategies’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-595
| Closed | -$1.28K | – | 2430 |
|
|
2024
Q3 | $1.28K | Sell |
595
-3,285
| -85% | -$7.06K | ﹤0.01% | 1386 |
|
|
2024
Q2 | $20K | Buy |
+3,880
| New | +$20K | ﹤0.01% | 1284 |
|
|
2022
Q3 | – | Sell |
-1,128
| Closed | -$11K | – | 3955 |
|
|
2022
Q2 | $11K | Sell |
1,128
-927
| -45% | -$9.04K | ﹤0.01% | 3722 |
|
|
2022
Q1 | $24K | Sell |
2,055
-477
| -19% | -$5.57K | ﹤0.01% | 3442 |
|
|
2021
Q4 | $83K | Sell |
2,532
-6,167
| -71% | -$202K | ﹤0.01% | 3236 |
|
|
2021
Q3 | $389K | Sell |
8,699
-17,101
| -66% | -$765K | ﹤0.01% | 2196 |
|
|
2021
Q2 | $1.41M | Buy |
25,800
+23,197
| +891% | +$1.26M | 0.02% | 1335 |
|
|
2021
Q1 | $195K | Sell |
2,603
-1,208
| -32% | -$90.5K | ﹤0.01% | 2488 |
|
|
2020
Q4 | $414K | Buy |
3,811
+2,956
| +346% | +$321K | 0.01% | 1874 |
|
|
2020
Q3 | $76K | Sell |
855
-1,053
| -55% | -$93.6K | ﹤0.01% | 2326 |
|
|
2020
Q2 | $203K | Buy |
1,908
+1,891
| +11,124% | +$201K | ﹤0.01% | 2025 |
|
|
2020
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 2124 |
|
|
2019
Q1 | – | Sell |
-53
| Closed | -$3K | – | 2453 |
|
|
2018
Q4 | $3K | Sell |
53
-137
| -72% | -$7.76K | ﹤0.01% | 2006 |
|
|
2018
Q3 | $23K | Sell |
190
-977
| -84% | -$118K | ﹤0.01% | 1763 |
|
|
2018
Q2 | $119K | Buy |
+1,167
| New | +$119K | 0.01% | 1486 |
|
|
2017
Q4 | – | Sell |
-1,013
| Closed | -$149K | – | 2132 |
|
|
2017
Q3 | $149K | Buy |
+1,013
| New | +$149K | 0.01% | 1544 |
|